Strides Pharma Science has informed that R Ananthanarayanan, Chief Executive Officer and Managing Director of the Company, is also appointed as Key Managerial Personnel of the Company effective January 9, 2020. Accordingly, in terms of SEBI Listing Regulations, he is also authorized to determine materiality of an event or information and to make disclosures to Stock Exchanges as required under the said Regulation.
The above information is a part of company’s filings submitted to BSE.